Research map: Nectin-4 and Trop-2 expression in collecting duct carcinoma: new promising therapeutic targets

Back to the article

Papers in this map

  1. Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma · Thomas B. Powles · 2021 · 1236 citations · Cited by this paper
  2. Collecting duct carcinoma: new biological inroads in this rarest of rare cancers · R. Agarwal · 2026 · Cites this paper
  3. 61eP Radiotherapy combined with PARP inhibition in BRCA-mutated breast cancer: A systematic review of clinical outcomes and toxicity · 2026 · Related
  4. TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors · Scott T. Tagawa · 2021 · 553 citations · Cited by this paper
  5. 149P Adjuvant radiotherapy outcomes for early stage (stage 1c-2) clear cell ovarian carcinoma in Edinburgh cancer centre · 2026 · Related
  6. Prospective Multicenter Phase II Study of Gemcitabine Plus Platinum Salt for Metastatic Collecting Duct Carcinoma: Results of a GETUG (Groupe d’Etudes des Tumeurs Uro-Génitales) Study · Stéphane Marie. Oudard · 2007 · 202 citations · Cited by this paper
  7. 213P Glandular tissue–based versus anatomical landmark–based CTV delineation in postoperative breast cancer radiotherapy: A dosimetric comparison · 2026 · Related
  8. Renal collecting (Bellini) duct carcinoma displays similar characteristics to upper tract urothelial cell carcinoma · Anna Orsola · 2005 · 77 citations · Cited by this paper
  9. 194eP Ovarian cancer during pregnancy: Maternal and fetal outcomes from a systematic review and meta-analysis · 2026 · Related
  10. Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma · Giuseppe Procopio · 2022 · 62 citations · Cited by this paper
  11. 67RO Single-cell and TCR profiling reveals pre-existing cytotoxic CD8 T cell clonal expansion and peripheral–tumor dissociation associated with response to PD-1-based therapy in hepatocellular carcinoma · 2026 · Related
  12. Incidence, Clinical Characteristics, and Survival of Collecting Duct Carcinoma of the Kidney: A Population-Based Study · Chaopeng Tang · 2021 · 28 citations · Cited by this paper
  13. 219P Clinical profile and treatment outcomes of lymphoma patients: A retrospective cohort study · 2026 · Related
  14. A phase Ib/II, open-label, multicenter, randomized umbrella study evaluating the combination of atezolizumab with sacituzumab govitecan in patients with locally advanced or metastatic urothelial carcinoma and previously treated with a platinum-based treatment regimen (MORPHEUS-Urothelial Carcinoma) · 2026 · Related
  15. 152P Efficacy and safety of relacorilant + nab-paclitaxel in patients aged ≥65 years with platinum-resistant ovarian cancer (PROC) in the phase III ROSELLA study (GOG-3073, ENGOT-ov72, APGOT-Ov10) · 2026 · Related
  16. 232eP GLP-1 receptor agonists and risk of incident endometrial, colorectal, and hepatocellular cancer: A systematic review and meta-analysis · 2026 · Related
  17. 174eP Progesterone receptor expression and endocrine therapy outcomes in low-grade serous ovarian carcinoma · 2026 · Related

Source: OpenAlex (CC0)